胆石症における血清CA19-9の臨床的意義について

概要

論文の詳細を見る
Serum CA19-9 levels were measured using radioimmunoassay in 45 patients with cholelithiasis and clinical significance of serum CA19-9 was discussed. Results obtained were as follows:1) Positive rate over cut off level of CA19-9 (>37U/ml) was 27.6% in patients with cholecystolithiasis and 68.8% with choledocholithiasis.2) Positive rate of serum CA19-9 was high in patients with clinical symptoms such as cholecystitis, cholangitis and obstructive jaundice. The highest titer of CA19-9 was 2350U/ml in a patient with obstructive jaundice.3) High titer of serum CA19-9 was improved in patients with cholecystolithiasis after subsidence of cholecystitis.4) There was positive correlation between serum total bilirubin and serum CA19-9 in patients with choledocholithiasis. High titer of serum CA19-9 was normalized in all cases after improvement of obstructive jaundice.It is suggested by these results that CA19-9 is secreted into bile and this antigen flows back into blood in situation of cholecystitis or obstruction of bile duct.
財団法人日本消化器病学会の論文